(Q42452556)

31 October 2017

title

Statins differentially regulate vascular endothelial growth factor synthesis in endothelial and vascular smooth muscle cells (English)

1 reference

31 October 2017

0 references

7

1 reference

31 October 2017

4

Alicja Józkowicz

1 reference

31 October 2017

2

Jozef Dulak

1 reference

31 October 2017

6

Hannes Alber

1 reference

31 October 2017

3

Jarosław Cisowski

1 reference

31 October 2017

Severin P Schwarzacher

series ordinal

8

object named as

Severin P Schwarzacher

1 reference

31 October 2017

5

Ralf Zwick

1 reference

31 October 2017

9

Otmar Pachinger

1 reference

31 October 2017

Matthias Frick

1

1 reference

31 October 2017

Franz Weidinger

series ordinal

10

1 reference

31 October 2017

publication date

1 October 2003

1 reference

31 October 2017

1 reference

31 October 2017

volume

170

1 reference

31 October 2017

issue

2

1 reference

31 October 2017

page(s)

229-236

1 reference

Current perspectives on statins

31 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Statins do more than just lower cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Direct vascular effects of HMG-CoA reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Molecular mechanisms of blood vessel growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Lovastatin and tumor necrosis factor-alpha exhibit potentiated antitumor effects against Ha-ras-transformed murine tumor via inhibition of tumor-induced angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Vascular endothelial growth factor: angiogenesis, atherogenesis or both?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Vascular endothelial growth factor synthesis in vascular smooth muscle cells is enhanced by 7-ketocholesterol and lysophosphatidylcholine independently of their effect on nitric oxide generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Statins have biphasic effects on angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Double-edged role of statins in angiogenesis signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Atorvastatin decreases vascular endothelial growth factor in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Effect of human recombinant vascular endothelial growth factor165 on progression of atherosclerotic plaque

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Vascular endothelial growth factor enhances atherosclerotic plaque progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Acidosis inhibits endothelial cell apoptosis and function and induces basic fibroblast growth factor and vascular endothelial growth factor expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Role of Akt signaling in vascular homeostasis and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Simvastatin reduces neointimal thickening in low-density lipoprotein receptor-deficient mice after experimental angioplasty without changing plasma lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

10.1016/S0021-9150(03)00299-5

7 January 2021

Identifiers

DOI

1 reference

31 October 2017

1 reference